Laddar...
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
BACKGROUND: A previous phase I/II C-TASK FORCE study of trifluridine/tipiracil plus bevacizumab for patients with heavily pretreated metastatic colorectal cancer (mCRC) showed promising activity with an acceptable toxicity profile. This retrospective study aimed to investigate the safety and efficac...
Sparad:
| I publikationen: | BMC Cancer |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935149/ https://ncbi.nlm.nih.gov/pubmed/31881856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6475-6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|